US Diabetes Care Drugs Market Share

Statistics for the 2023 & 2024 US Diabetes Care Drugs market share, created by Mordor Intelligence™ Industry Reports. US Diabetes Care Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Pharmaceuticals Research Disease Specific Drugs Research Chronic Disorder Drugs Research Diabetes Care Drugs Research Diabetes Care Drugs Market in US Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of US Diabetes Care Drugs Industry

Manufacturers have constantly innovated to compete and battle in the industry under study. According to a new study on the SGLT2 Class (Jardiance, Farxiga), medicine aids in treating renal and cardiovascular illnesses.

US Diabetes Care Drugs Market Leaders

  1. Eli Lilly

  2. Boehringer Ingelheim

  3. Astrazeneca

  4. Sanofi

  5. NovoNordisk

*Disclaimer: Major Players sorted in no particular order

US Diabetes Care Drugs Market Concentration

United States Diabetes Care Drugs Market Report Snapshots

US Diabetes Care Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)